Summary

The global market for Neurovascular Devices was estimated to be worth US$ 3195 million in 2024 and is forecast to a readjusted size of US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Neurovascular devices are medical devices used to diagnose, treat, and manage various diseases affecting the blood vessels in the brain and nervous system. Neurovascular diseases typically include conditions such as stroke (both ischemic and hemorrhagic), brain aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities. These devices play a critical role in neurovascular procedures, enabling minimally invasive treatments that enhance patient outcomes.
Common neurovascular devices include stents, coils, embolization devices, flow diversion devices, microcatheters, aspiration systems, and intracranial pressure (ICP) monitors. Stents are primarily used to treat narrowed blood vessels, often in patients with cerebral aneurysms or carotid artery disease. Coils are used to embolize brain aneurysms, promoting clot formation inside the aneurysm and reducing the risk of rupture. Flow diversion devices are used to alter blood flow in the brain, typically for aneurysm treatment, to reduce the risk of rupture. Microcatheters and embolization devices are mainly used to occlude abnormal blood vessels in conditions like AVMs or tumors. Aspiration devices are employed to remove blood clots in acute ischemic strokes, restoring blood flow to the brain.
These devices have significantly advanced the treatment of neurovascular diseases, improving the precision and safety of procedures. As medical technology progresses, the role of these devices in minimally invasive surgeries continues to grow, and they will remain essential in the development of the field of neurointervention and neurosurgery.
1. Market Development Opportunities and Key Drivers:
The market for neurovascular devices is driven by several key factors:
Rising Stroke Incidence: As the global population ages, the incidence of strokes, especially ischemic strokes, continues to increase, driving demand for neurovascular devices.
Technological Advancements: With the development of minimally invasive technologies, neurovascular procedures have become more precise and safer. New devices and materials, such as flow diversion devices and automated aspiration systems, have made neurointerventional procedures more efficient and feasible.
Expanded Healthcare Coverage: The expansion of healthcare insurance systems and increasing healthcare expenditures have driven the demand for effective medical devices.
Increased Health Awareness: As public awareness of cerebrovascular diseases rises, there is a growing demand for early diagnosis and prevention, further fueling the neurovascular device market.
2. Market Risks:
High Treatment Costs: Neurovascular devices are often expensive, particularly high-end devices and treatments, which may create entry barriers in developing countries.
Technological Risks: The development of new technologies is uncertain, requiring long clinical trials and regulatory approvals. Additionally, the rapid pace of technological advancements may render products obsolete.
Regulatory and Compliance Risks: The approval process for medical devices is stringent, especially for new technologies, and regulatory challenges may hinder market adoption.
3. Market Concentration:
The neurovascular device market is relatively concentrated, with a few leading global medical device companies dominating the market. Major players include Medtronic, Stryker, Boston Scientific, and others. These companies have strong R&D capabilities and extensive distribution networks, enabling them to provide high-quality products and maintain a dominant position globally.
4. Downstream Demand Trends:
Increasing Demand Due to Aging Population: As the global population ages, the prevalence of cerebrovascular diseases such as strokes continues to rise, driving the demand for neurovascular treatments and devices.
Preference for Minimally Invasive Procedures: Patients increasingly prefer minimally invasive surgeries, which reduce hospital stays and recovery times, leading to a growing demand for minimally invasive neurovascular devices.
Customized Treatment Needs: With the advancement of precision medicine, there is an increasing demand for personalized treatment solutions, which has led to the development of tailored neurovascular devices.
5. Latest Technologies:
Flow Diversion Devices: This technology has made significant progress in treating brain aneurysms, especially in high-risk patients, by diverting blood flow away from the aneurysm to reduce the risk of rupture.
Automated Aspiration Systems: These systems are used for clot retrieval in acute ischemic stroke, enabling rapid and effective restoration of blood flow to the brain.
Minimally Invasive Surgical Systems: Recent advancements in minimally invasive surgery have made neurovascular procedures more precise, reducing surgical risks and recovery times by using smaller catheters and more accurate techniques.
This report aims to provide a comprehensive presentation of the global market for Neurovascular Devices, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Neurovascular Devices by region & country, by Type, and by Application.
The Neurovascular Devices market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Devices.
Market Segmentation
By Company
Stryker Corporation
Johnson & Johnson
Medtronic
Terumo Neuro
Penumbra, Inc. (Neuro)
Shanghai MicroPort Medical (Group) Co.，Ltd.
Abbott Vascular
Medical Murray
Boston Scientific
Segment by Type
Thrombectomy Devices
Intracranial Stents
Embolization Devices
Flow Diversion Devices
Others
Segment by Application
Stroke Treatment
Aneurysm Treatment
Cerebral Vascular Stenosis Treatment
Traumatic Brain Injury and Intracranial Hemorrhage Treatment
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Neurovascular Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Neurovascular Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Neurovascular Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Neurovascular Devices Product Introduction
1.2 Global Neurovascular Devices Market Size Forecast (2020-2031)
1.3 Neurovascular Devices Market Trends & Drivers
1.3.1 Neurovascular Devices Industry Trends
1.3.2 Neurovascular Devices Market Drivers & Opportunity
1.3.3 Neurovascular Devices Market Challenges
1.3.4 Neurovascular Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Neurovascular Devices Players Revenue Ranking (2024)
2.2 Global Neurovascular Devices Revenue by Company (2020-2025)
2.3 Key Companies Neurovascular Devices Manufacturing Base Distribution and Headquarters
2.4 Key Companies Neurovascular Devices Product Offered
2.5 Key Companies Time to Begin Mass Production of Neurovascular Devices
2.6 Neurovascular Devices Market Competitive Analysis
2.6.1 Neurovascular Devices Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Neurovascular Devices Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Devices as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Thrombectomy Devices
3.1.2 Intracranial Stents
3.1.3 Embolization Devices
3.1.4 Flow Diversion Devices
3.1.5 Others
3.2 Global Neurovascular Devices Sales Value by Type
3.2.1 Global Neurovascular Devices Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Neurovascular Devices Sales Value, by Type (2020-2031)
3.2.3 Global Neurovascular Devices Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Stroke Treatment
4.1.2 Aneurysm Treatment
4.1.3 Cerebral Vascular Stenosis Treatment
4.1.4 Traumatic Brain Injury and Intracranial Hemorrhage Treatment
4.1.5 Others
4.2 Global Neurovascular Devices Sales Value by Application
4.2.1 Global Neurovascular Devices Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Neurovascular Devices Sales Value, by Application (2020-2031)
4.2.3 Global Neurovascular Devices Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Neurovascular Devices Sales Value by Region
5.1.1 Global Neurovascular Devices Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Neurovascular Devices Sales Value by Region (2020-2025)
5.1.3 Global Neurovascular Devices Sales Value by Region (2026-2031)
5.1.4 Global Neurovascular Devices Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Neurovascular Devices Sales Value, 2020-2031
5.2.2 North America Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Neurovascular Devices Sales Value, 2020-2031
5.3.2 Europe Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Neurovascular Devices Sales Value, 2020-2031
5.4.2 Asia Pacific Neurovascular Devices Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Neurovascular Devices Sales Value, 2020-2031
5.5.2 South America Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Neurovascular Devices Sales Value, 2020-2031
5.6.2 Middle East & Africa Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Neurovascular Devices Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Neurovascular Devices Sales Value, 2020-2031
6.3 United States
6.3.1 United States Neurovascular Devices Sales Value, 2020-2031
6.3.2 United States Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Neurovascular Devices Sales Value, 2020-2031
6.4.2 Europe Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Neurovascular Devices Sales Value, 2020-2031
6.5.2 China Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.5.3 China Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Neurovascular Devices Sales Value, 2020-2031
6.6.2 Japan Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Neurovascular Devices Sales Value, 2020-2031
6.7.2 South Korea Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Neurovascular Devices Sales Value, 2020-2031
6.8.2 Southeast Asia Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Neurovascular Devices Sales Value, 2020-2031
6.9.2 India Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.9.3 India Neurovascular Devices Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Stryker Corporation
7.1.1 Stryker Corporation Profile
7.1.2 Stryker Corporation Main Business
7.1.3 Stryker Corporation Neurovascular Devices Products, Services and Solutions
7.1.4 Stryker Corporation Neurovascular Devices Revenue (US$ Million) & (2020-2025)
7.1.5 Stryker Corporation Recent Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Profile
7.2.2 Johnson & Johnson Main Business
7.2.3 Johnson & Johnson Neurovascular Devices Products, Services and Solutions
7.2.4 Johnson & Johnson Neurovascular Devices Revenue (US$ Million) & (2020-2025)
7.2.5 Johnson & Johnson Recent Developments
7.3 Medtronic
7.3.1 Medtronic Profile
7.3.2 Medtronic Main Business
7.3.3 Medtronic Neurovascular Devices Products, Services and Solutions
7.3.4 Medtronic Neurovascular Devices Revenue (US$ Million) & (2020-2025)
7.3.5 Medtronic Recent Developments
7.4 Terumo Neuro
7.4.1 Terumo Neuro Profile
7.4.2 Terumo Neuro Main Business
7.4.3 Terumo Neuro Neurovascular Devices Products, Services and Solutions
7.4.4 Terumo Neuro Neurovascular Devices Revenue (US$ Million) & (2020-2025)
7.4.5 Terumo Neuro Recent Developments
7.5 Penumbra, Inc. (Neuro)
7.5.1 Penumbra, Inc. (Neuro) Profile
7.5.2 Penumbra, Inc. (Neuro) Main Business
7.5.3 Penumbra, Inc. (Neuro) Neurovascular Devices Products, Services and Solutions
7.5.4 Penumbra, Inc. (Neuro) Neurovascular Devices Revenue (US$ Million) & (2020-2025)
7.5.5 Penumbra, Inc. (Neuro) Recent Developments
7.6 Shanghai MicroPort Medical (Group) Co.，Ltd.
7.6.1 Shanghai MicroPort Medical (Group) Co.，Ltd. Profile
7.6.2 Shanghai MicroPort Medical (Group) Co.，Ltd. Main Business
7.6.3 Shanghai MicroPort Medical (Group) Co.，Ltd. Neurovascular Devices Products, Services and Solutions
7.6.4 Shanghai MicroPort Medical (Group) Co.，Ltd. Neurovascular Devices Revenue (US$ Million) & (2020-2025)
7.6.5 Shanghai MicroPort Medical (Group) Co.，Ltd. Recent Developments
7.7 Abbott Vascular
7.7.1 Abbott Vascular Profile
7.7.2 Abbott Vascular Main Business
7.7.3 Abbott Vascular Neurovascular Devices Products, Services and Solutions
7.7.4 Abbott Vascular Neurovascular Devices Revenue (US$ Million) & (2020-2025)
7.7.5 Abbott Vascular Recent Developments
7.8 Medical Murray
7.8.1 Medical Murray Profile
7.8.2 Medical Murray Main Business
7.8.3 Medical Murray Neurovascular Devices Products, Services and Solutions
7.8.4 Medical Murray Neurovascular Devices Revenue (US$ Million) & (2020-2025)
7.8.5 Medical Murray Recent Developments
7.9 Boston Scientific
7.9.1 Boston Scientific Profile
7.9.2 Boston Scientific Main Business
7.9.3 Boston Scientific Neurovascular Devices Products, Services and Solutions
7.9.4 Boston Scientific Neurovascular Devices Revenue (US$ Million) & (2020-2025)
7.9.5 Boston Scientific Recent Developments
8 Industry Chain Analysis
8.1 Neurovascular Devices Industrial Chain
8.2 Neurovascular Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Neurovascular Devices Sales Model
8.5.2 Sales Channel
8.5.3 Neurovascular Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer